Novo Nordisk Lilly Shares Slump on Price-Cut Loom Plans
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
This analysis highlights how long-term returns vary across index funds, emphasizing the impact on portfolio resilience.
28,357 articlesNews of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Jim Cramer spotlights a surprising quarter from Marvell, arguing the company’s data center-focused growth could redef...
Market chatter centers on Caterpillar as a top pick amid rising oil demand, renewed infrastructure spending, and a su...
A landmark move by the European Commission forces Meta to open WhatsApp to rival AI chatbots. The order could reshape...
Oracle's AI strategy is under scrutiny as earnings shed light on backlog and cash needs. We see roughly 46-47% upside...
In the wake of the State Of The Union address, mortgage rates danced around 6% as markets priced in housing policy si...
Bumble reports softer user growth and a hefty impairment bill, even as cash flow improves. The AI-driven reboot is dr...
May 2026 brings a surprising shift: homes stay on the market longer than in years past. This guide explains what's dr...
Analysts warn that the AI data center boom championed by leading tech firms may deliver far less capacity than promis...
A stalled search for the Atlanta Fed president is drawing attention to leadership dynamics at the central bank, as Ke...
AI fears roiled tech names, dragging CrowdStrike lower despite strong fundamentals. Analysts see a 40% upside as sent...
U.S. equities climbed on Friday as top performing stocks led a broad rally, with technology and energy names pushing ...